Background and Motivation
The application of natural language processing (NLP) is useful for biomedical scientists to retrieve valuable information from numerous biological publications. Among bio-NLP tasks, biomedical named entity recognition (BNER) is the fundamental but critical one to conquer. Hence, there are many BNER corpora developed for this purpose. For instance, Arizona Disease Corpus (AZDC) [1] is one of the well-known bio-NER corpora. The AZDC corpus contains 793 PubMed abstracts for the disease entity recognition task which is less discussed. Moreover, GENIA corpus [2] is collected by retrieving abstracts associated with specific MEDLINE query terms such as "human", "blood cells" and "transcription factors". Based on the GENIA ontology [3] , the recruited knowledge is well-organized in this corpus. The release of the GENIA corpus promoted text-mining studies in the field of molecular biology and it serves as the seed for several tasks where truthful training and test sets can be constructed.
However, the earlier NER corpora are gradually unsatisfactory to corresponding applications since the development of information extraction studies progresses rapidly ever than before. Take AZDC corpus as an example, the dataset is improved at the entity level and generated the specific identifiers from MeSH or OMIM databases for disease normalization [4] . In contrast to the more detailed corpus revision, combination of trivial concepts to hyper definitions is another direction to promote ideal corpus. The JNLPBA 2004 shared task [5] is derived from five superclasses in the GENIA corpus while the entities are named protein, DNA, RNA, cell line and cell type, respectively.
Due to the complexity of the gene name nomenclature and composition [6] , there are several ways to present gene entities in different gene mention corpora. In JNLPBA corpus, the gene mentions are divided into protein, DNA and RNA which included not only specific gene names but also corresponding general sequence information which are seldom referred to as interested entities in biological fields. Another gene mention dataset, GENETAG [7] rules out the general sequence mentions in annotations and considers protein, DNA and RNA as the same entity type since the inclusion allows to reduce the unnecessary disambiguation process. More recently, Gene and Protein Related Object (GPRO) task [8] builds up the GPRO corpus with proposing two types of entity mention definitions: GPRO entity mention type 1 and type 2. All the entities covered in GPRO entity mention type 1 are able to be normalized while entities in type 2 are not. Nevertheless, the gene mentions in GPRO entity mention type 2 represent to the protein family terms or multiple gene mentions rather than the general bio-entities.
Despite the standard of gene mentions annotations has been transformed from general gene mentions to more compatible annotation for relation extraction. However, the standard of original corpora still have their reputation, therefore, even recently published works still have to use these corpora to evaluate their approaches (despite the corpus annotations do not fit real application). Another common issue of earlier corpora is that they have either smaller scale or lower annotation consistency because they have to spend more efforts in collecting data and defining annotation standard. Therefore, if a proposed algorithm uses the corpus for evaluation, and get poor results, it is hard to distinguish whether the lower performances come from their algorithm designs or not.
In the paper, we developed a revised version of JNLPBA corpus. We believe that it would be an alternative option for those who use the JNLPBA corpus and get lower performance. Meanwhile, several odd situations found in original JNLPBA are pointed out with relevant cases to emphasize the necessity of corpus revision. It is especially helpful for those who cannot figure out whether the lower performances stand for the inappropriate algorithm designs or not. To measure the efficacy of using Revised JNLPBA, two experiments are conducted. Three widely mentioned NER systems (BANNER [9] , Gimli [10] and NERsuite [11] ) are introduced in both experiments to evaluate the corpora. In the first experiment, NER systems are trained on both corpora and tested in the corresponding test set. The performance can be a fair reference to judge the annotation consistency of each corpus. To further examine the adaptability of corpus after revision, we integrate five Protein-Protein Interaction Extraction (PPIE) and five Biomedical Event Extraction (BEE) corpora for the validation. All gene mentions in above relation extraction corpora are the prediction targets while the two JNLPBA corpora are utilized for training, respectively.
By the comparisons between the Revised JNLPBA and before, users can select the preferable corpus for their projects according to the needs. In summary, the Revised JNLPBA corpus engages the purities of annotation for researchers who tend to focus on the specific gene mention identification instead of the DNA/protein sequences or the mentions of gene/protein fragments. Moreover, the elusive entity boundaries in the original corpus are also found and improved. Without the interference of the nonspecific terms and the boundary confusion, the defects hidden in the desired module is easier to be verified. Finally, the Revised JNLPBA broadens the corpus availability to explore the advanced relation extraction task which the included gene mentions show similar annotation criteria.
JNLPBA Annotations
In this section, we summarize the imperfections of current JNLPBA corpus and raise the explanations for why we consider that these types of annotations are inappropriate. The term "-795bp" is the position of the DNA sequence (counting from the transcription start site), which is not annotated in the PPIE and BEE corpora, but was referred to as a DNA in the JNLPBA corpus.
Second, some entities include redundant preceding words that do not exist in the original name in the database. For example, "truncated RARalpha" is marked as a protein in JNLPBA, but the term "truncated" cannot provide any useful identity information to "RARalpha" and therefore should be excluded.
In addition, due to the large size of the corpus, there are some missing annotations and incorrect assignment of BNE type in the JNLPBA corpus.
Moreover, there are some inconsistencies that may cause misunderstandings if one attempts to map the entities back to the corresponding ID in standard databases or organize them into clusters. The inconsistencies can be generally classified into five types, including the recruitments of general terms, unnecessary preceding words, entity type confusion, neglected adjacent clues, and missing annotations. The following paragraphs describe examples regarding each type of the confusions that can be found in the GENIA corpus.
Problem of general terms
Specific entities containing unique names can be clearly recognized in the database or certain groups they belong to, while some entities possess only general properties. It is not appropriate for the latter type to be assigned the same label as the former. So, it is better to remove the so-called general terms or assign other tags to them. The following example expresses the appearance of general terms:
"Substitution mutations in this consensus sequence eliminate binding of the inducible factor."
MEDLINE: 97138389
The bold terms are labeled as DNA and protein respectively in GENIA corpus but both of them lack the major features to become specific BNEs.
Unnecessary preceding words
The information beyond entities often provides intrinsic properties or external status to make the entities more intact. The intrinsic information is important to assist the assignments of correct identities, so it is suitable to be recruited as part of entities. For example, "human" and "murine" can serve as the evidence to separate the same "IL-2" into different gene IDs. However, extrinsic information sometimes could depict additional properties that are not helpful when distinguishing these entities.
The following instance serves to illustrate this type of words:
"Expression of dominant negative MAPKK-1 prevents NFAT induction."
MEDLINE: 96324400
"MAPKK-1" is the core of bold terms, while "dominant negative" is regarded as a mutant type of protein. The latter biological term carries no useful message if one tries to find the real source of "MAPKK-1". Table 1 gives the numbers of general terms and unnecessary preceding words in JNLPBA corpus. 
Entity type confusion
Some entity types in the GENIA corpus are related to each other, and this association may sometimes cause misclassification of the entity type. By comparing the following two sentences, it is clear that labels are inconsistent.
"… that the type II IL-1R does not mediate gene activation in Jurkat cells."

MEDLINE: 93252936
"…galectin-3 was shown to activate interleukin-2 production in Jurkat T cells."
MEDLINE: 96208140
The two similar bold entities are labeled as cell line and cell type, respectively, in this instance. However, the core term "Jurkat" is a powerful attribution to annotate both of them as cell line.
Neglected adjacent clues
In some cases, the entities are concatenated with a certain type of keywords, so it is easy to clarify the real types of entities. But several observations indicate that a few of the keywords are neglected in the GENIA corpus, such as the example below:
"The 5' sequences up to nucleotide -120 of the human and murine IL-16 genes …"
MEDLINE: 96324400
Without considering the keyword "genes", the bold term "IL-16" was wrongly classified into the protein type.
Missing annotations
This is hard to avoid when the corpus size is huge. GENIA corpus also suffered from this problem. The following sentence displays missing annotations:
"Three additional smaller regions show homology to the ELK-1 and SAP-1 genes…"
MEDLINE: 94217726
According to the GENIA ontology, the bold term "ELK-1" should be referred to as DNA, but it is missing.
In order to obtain more consistent annotations and a reliable source for both entity linking and relation extraction tasks, we had domain experts carefully check and revise the JNLPNA corpus.
Annotation Guideline
Annotators
For revising JNLPBA, we recruited two curators. Both had a biological background, curation and natural language processing experiences. Annotator 1 is a Ph.D. candidate with biological, chemical and medical background. Annotator 2 is a full-time master research assistant with biological, chemical and computer science background.
Annotator 2 also had extensive curation experiences. Each article was annotated independently by the two annotators. Differences were resolved through discussion.
Annotation tool
The curators used the brat annotation tool to manually revise the annotations of the JNLPBA corpus according to the annotation guideline. 
General Rules
Specific Rules
There is an important principle that must be elucidated first before explaining the detailed criteria of specific rules. The principle is that, when the target NE and surrounding contexts cannot provide any evidence to support the assignment of NE Moreover, the preserved adjectives often provide the intrinsic properties of described NEs. For example, "human" would be included in "human GM-CSF gene" because it is related to the NE's species and can help biologists to determine the NE's identifier.
In contrast, "abnormal" would be excluded from "abnormal blast cells" since the adjective displays an extrinsic property of target NE. and "domain", rather than a full protein are not included in the protein NE. In addition, the potential protein NEs usually obtain some similar suffixes to represent properties of protein, e.g. protein, receptor, antigen, antibody, enzyme, (transcription) factor and kinase. Thus, the NEs ending with above keywords should be labeled as protein NEs.
Moreover, the molecular mass (e.g., "55 kd" in "55 kd TNFR") is a clue to classify the target NE into protein type rather than DNA or RNA. 
Inter-annotator Agreement (IAA) Analysis
To evaluate the consistency of the annotation, we used Cohen's kappa coefficient. As shown below, κ is the kappa value. 0 is the relative observed agreement among annotators, and is the hypothetical probability of chance agreement. 
Experiment Results
We design two experiments to evaluate the effects of using Revised JNLPBA corpus.
In the first experiment, we compare the performances of commonly-used NER systems trained on JNLPBA and Revised JNLPBA respectively. In the second experiment, we train the NER systems on the two editions of JNLPBA and evaluate their performances on Protein-Protein Interaction Extraction (PPIE) and Biomedical Event Extraction (BEE) corpora. PPIE datasets include LLL [12] , AImed [13] , BioInfer [14] , IEPA [15] and HPRD50 [16] . BEE datasets include BioNLP 2013 ST GRO, GE, GRN, CG and PC datasets [17] . We removed all non-gene and cell-related NE annotations from these datasets and combined them into the BRE corpus.
Evaluation Metrics
The performance is given in terms of F1-measure and is calculated by using the evaluation script from JNLPBA.
BNER Systems
Three BNER systems were used for comparison, including BANNER [9] , Gimli [10] , and NERsuite [11] . We selected these systems because they are available BNER systems and achieved state-of-the-art performances on either JNLPBA or GENETAG.
All of them are based on Conditional Random Fields (CRF). The following table summarized the characteristics of these systems. 
Experiment 1
In this experiment, JNLPBA training and test set were used for compared systems. Table 3 shows the performances of different approaches on the test set. We suspect that lower score of BANNER might be that the feature selection in the BANNER system was based on the BioCreative II GM dataset rather than the JNLPBA dataset.
The inconsistencies in the JNLPBA, likely due to annotators with different annotation criteria, create a bottleneck on the BNER performances. To alleviate any negative effects bringing by this problem, we revised the dataset basis on the annotation guideline. The corresponding performances are shown in Table 3 . Generally, the overall performances of NER systems can reach at least 10% higher in Revised JNLPBA than the original one. 
Experiment 2
In this experiment, the two JNLPBA corpora were used for training NER open-source systems. Subsequently, PPIE and BEE corpora are served as test set to evaluate the performances. The F-scores of the systems were shown in Table 4 
Conclusion
The progression of biomedical text mining is urgently required in the era of information explosion. Each mature machine learning model is built on not only the well-designed algorithms but also the reliable validation mechanism. Inconsistent annotations make the learning systems confusion. And It is hard to discriminate the truth hidden in the biological texts since there are various nomenclature forms depending on the distinct domains. With a confidential corpus, researchers can concentrate on improving their own systems rather than clarifying the causes of unexpected performance. In this work, we propose a revised edition of JNLPBA corpus. Several imperfections found in original JNLPBA corpus are pointed out and corrected as much as possible. According to the evaluation of different NER systems, we believe that the corpus performs higher consistency than before after revision process. The further application adaptability of revised JNLPBA is also examined via the open tests on PPIE and BEE corpora. In overall, the revised JNLPBA is competent for the systems which required gene mention entities training for relation extraction purpose. We envision the revised JNLPBA corpus can become another option for the researchers who engage in the BNER or BRE issues.
